Deletion of Asah2 alleviates diet-induced nonalcoholic steatohepatitis/nonalcoholic fatty liver disease via downregulation of stearoyl-CoA desaturase (Scd1) and reduces cholesterol accumulation (75). This evidence concerns the gene SCD and metabolic dysfunction-associated steatohepatitis.